Nostrum Labs joins growing list of NDMA metformin recalls
Nostrum Laboratories has issued a voluntary recall of 2 lots of their 750 mg extended release metformin tablets (100 tablet packages) due to elevated levels of the human carcinogen N-nitrosodimethylamine (NDMA). Nostrum did not specify the number of bottles recalled.
Products Recalled:
100 tablet HDPE bottles
NDC 29033-055-01
Lot Numbers -
MET100201 (expires May 2022)
MET100401 (expires May 2022)
May of this year is when we first began to see companies recall their metformin tabs due to NDMA contamination. Companies such as Teva, Lupin, Apotex, and more all initiated recalls at the time. Some companies only recalled a 1 or 2 lots, while others went so far as to pull all of their products off store shelves entirely.
To read Fierce Pharma’s full story on the recall, follow this link: https://bit.ly/3lelrvD